BUPICAN

This brand name is authorized in Brazil, Estonia, South Africa

Active ingredients

The drug BUPICAN contains one active pharmaceutical ingredient (API):

1 Bupivacaine
UNII 7TQO7W3VT8 - BUPIVACAINE HYDROCHLORIDE

Bupivacaine is an amide-type, long-acting local anesthetic. Bupivicaine reversibly binds to specific sodium ion channels in the neuronal membrane, resulting in a decrease in the voltage-dependent membrane permeability to sodium ions and membrane stabilization; inhibition of depolarization and nerve impulse conduction; and a reversible loss of sensation.

Read about Bupivacaine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
BUPICAN Solution for injection Health Products Regulatory Authority (ZA) MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N01BB01 Bupivacaine N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Cรขmara de Regulaรงรฃo do Mercado de Medicamentos Identifier(s): 533021090075717, 533021090075817, 534100501156410
Country: EE Ravimiamet Identifier(s): 1784910
Country: ZA Health Products Regulatory Authority Identifier(s): 45/4/0127

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.